Tanaka, R; Kawamura, M; Mizutani, S; Hakamatsuka, T; Kikura-Hanajiri, R. Identification of three arylcyclohexylamines (MXPr, MXiPr, and DMXE) in illegal products Yakugaku Zasshi, 1 Jan 2022, 142 (6), 675–681. 1.0 MB. https://doi.org/10.1248/yakushi.21-00235 #3 GC,LC,MS,NMR,UV
Irie, T; Yanase, Y; Demizu, Y; Usami, M; Kikura-Hanajiri, R. Derivatives of methoxetamine and major methoxetamine metabolites potently block NMDA receptors J. Pharmacol. Sci., 1 Dec 2022, 150 (4), 233–243. 2.9 MB. https://doi.org/10.1016/j.jphs.2022.09.005 #DMXE
4′-Methyl-α-(pyrrolidin-1-yl)butanophenone · MPBP
4′-Methyl-α-(pyrrolidin-1-yl)isobutanophenone
O-2387 · α-(Pyrrolidin-1-yl)valerophenone · α-PVP
PPBO · α-(Piperidin-1-yl)butanophenone · α-PipBP
2,4-DMPPP · 2′,4′-Dimethyl-α-(pyrrolidin-1-yl)propanophenone
3-MPBP · 3′-Methyl-α-(pyrrolidin-1-yl)butanophenone
3,4-Trimethylenepentedrone
2-Keto-PCPr · 2′-Oxo-PCPr
N-(Cyclopropylmethyl)mephedrone · N-Cyclopropylmethyl-N-methyl-4-methylcathinone
3-Methyl-PPPO · 3′-Methyl-α-(piperidin-1-yl)propanophenone
N-Cyclopentyl-3-methylcathinone
α-(Pyrrolidin-1-yl)isovalerophenone · α-PiVP